why choose us

First received: October 19, 2022

Clinical Trial: A Study to Evaluate Vitamin B3 Derivative to Treat Mitochondrial Myopathy

Study Status: Completed

Recruit Status: RECRUITING

Condition: Mitochondrial Myopathy

Study Type: INTERVENTIONAL


Official Title: Randomized, Double-blinded, Placebo-controlled Study Evaluating the Efficacy of Nicotinamide Riboside (NR) - a Vitamin B3 Derivative - for Treatment of Mitochondrial Myopathy Disorder

Brief Summary: The purpose of this study is to determine the effects of Nicotinamide Riboside (NR) supplement in adult-onset symptoms of mitochondrial myopathy.

Read more